General Information
BounceWatch is an independent company data service, not affiliated with Walvax. To contact Walvax, visit en.walvax.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Walvax compare?
A PDF of Walvax and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Walvax soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Walvax on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
China Market
Biotechnology
About Walvax
Business keywords: Biological pharmaceutical company, Vaccines, Blood products, Biomedicine products, Meningococcal polysaccharide vaccine, Haemophilus influenzae type b conjugate vaccine, Infectious diseases, Preventive healthcare, Public health, Research and development, Bio-medicine, Medical innovation, China, Kunming
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post IPO Equity | $72.80M | - |
|
08 Aug 2014 |
Walvax Alternatives & Competitors
View All AlternativesAffinivax was acquired by GSK in August 2022. Affinivax is a clinical stage biotechnology company de...
A joint venture between SEEK Group and hVIVO, part of Open Orphan plc, to accelerate the development...
Pioneering the next generation of active immunotherapies for chronic diseases
FAQ About Walvax
Source: BounceWatch company record for Walvax, https://bouncewatch.com/company/walvax-biotechnology, updated 24 December 2024. When citing, please name BounceWatch and link this page.